Skip to content

Study Details

A Study of Single IV Dose of UX701 for Patients with Wilson Disease

(IRB#: IRB_00154398)

UX701is a medication for patients with Wilson's disease. Research is needed to learn the safety and effectiveness of single IV doses of UX701. The information we gain may aid future patients.

I AM INTERESTED

  • All genders
  • Over 18 years old
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: Over 18 years old

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Ages 18 years and older
  • Diagnosis of Wilson disease
  • Stable Wilson disease
  • In person at the University of Utah

Exclusion Criteria

  • Pregnant or breastfeeding
  • Presence or history of a health issue(s) that may not allow participation
  • Substance abuse 60 days before participation
  • Moderate to severe depression
  • History of liver transplant

Will I be paid for my time?

Yes

For more information contact:

Srinivas Mulmalla

srinivas.mulamalla@hsc.utah.edu

  801-581-7802

IRB#: IRB_00154398

PI: Juan Gallegos-Orozco

Department: GASTROENTEROLOGY

Approval Date: 2022-12-07 07:00:00

Specialties: Gastroenterology

Last Updated: 6/8/23